维普期刊资源整合服务平台（V6.5）

25篇 您的检索式：作者名="DE PLACIDO S"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	c -erbB2 expression predicts tamoxifen efficacy in breast cancer patients 显示文摘	De Placido S Cadomagno C De Laurentiis M	1998	Breast Cancer Res Treat1998，52，13：	1
2	A ran- domised factorial trial of sequential doxorubicin and CMF vs CMF and chemotherapy alone vs chemotherapy fol- lowed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer 显示文摘	De Placido S De Laurentiis M De Lena M	2005	Br J Cancer2005，92，3：	1
3	Residual neurotoxicity in ovariancancer patients in clinical remission after first-line chemotherapy with carboplatin andpaclitaxel: the Multicenter Italian Trial in Ovarian Cancer (MITO-4) retrospective study 显示文摘	Pignata S De Placido S Biamonte R	2006	BMC Cancer2006，6，：	1
4	Estrogen receptor-positive, proges- terone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resist- ance显示文摘	Arpino G Weiss H Lee A V Schiff R De Placido S Osborne C K	2005	J Natl Cancer Inst2005，97，：	1
5	Topotecan compared with no therapy alter response to surgery and carboplatin/ paclitaxel in patients with ovarian cancer: Multicenter Italian TriMs in Ovarian Cancer (MITO-1)randomized study 显示文摘	De Placido S Scambia G Di Vagno G	2004	J Clin Oneol2004，22，13：	1
6	In- creased risk of bladder cancer in critical areas at high pressure of pollution of the Campania region in Italy: A systematic review 显示文摘	DI LORENZO G FEDERICO P DE PLACIDO S	2015	Crit RevOncol Hematol2015，96，3：	1
7	Features of aggressive breast cancer显示文摘	Arpino G Milano M De Placido S	2015	Breast2015，24，5：	1
8	Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer:an open-label,2 x 2 factorial,randomised phase 3 trial显示文摘	Del ML De Placido S Bruzzi P	2015	Lancet2015，385，9980：	1
9	Management and treatment of triple - negative breast cancer patients from the NEMESI study:an Italian experience 显示文摘	Adamo V Ricciardi GR De Placido S	2012	Eur J Canc- er2012，48，5：	1
10	Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: the Multicenter Italian Trial in Ovarian cancer(MITO-4) retrospective study 显示文摘	Pignata S De Placido S Biamonte R	2006	BMC Cancer2006，6，：	1
11	C- erbB2 expression predicts tamoxifen efficacy in breast cancer patients显示文摘	De Placido S Carlomagno C De Laurentiis M	1998	Breast Cancer Res Treat1998，52，1：	1
12	Expression of biomarkers modulating prostate cancer progression:implications in the treatment of the disease显示文摘	Di Lorenzo G De Placido S Autorino R	2005	Prostate Cancer Prostatic Dis2005，8，1：	1
13	Topotecan compared with no therapy after response to surgery and carboplatinfpaelitaxel in patients with ovarian cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) randomized study显示文摘	De Placido S Scambia G Di Vagno G	2004	J Clin Oncol2004，22，13：	1
14	Expression of biomarkers modulating prostate cancer progression:implications in the treatment of the disease显示文摘	Di Lorenzo G De Placido S Autorino R	2005	Prostate Cancer Prostatic Dis2005，8，1：	1
15	Combined targeting of epidermal growth factor receptor and MDM2 by gefitinib and antisense MDM2 cooperatively inhibit hormone-independent prostate cancer显示文摘	Bianco R Caputo R Caputo R Damiano V De Placido S Ficorella C	2004	Clin Cancer Res2004，10，14：	1
16	Topotecan compared with no therapy after response to surgery and carboplatin/paclitaxel in patients with ovarian cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) randomized study 显示文摘	De Placido S Scambia G Di Vagno G	2004	J Clin Oncol2004，22，13：	1
17	A prognostic model that makes quantitative estimates of probability of relapse for breast cancer patients显示文摘	De Laurentiis M De Placido S Bianco AR		0，，12：	1
18	Hormone refractory prostate cancer (HRPC):present and future approaches of therapy显示文摘	Di Lorenzo G De Placido S	2006	Int J Immunapathol Pharmacol2006，19，1：	1
19	Topotecan compared with no therapy after response to surgery and carboplatin/paclitaxel in patients with ovarian cancer:multicenter italian trials in ovarian cancer (MITO-1)randomized study 显示文摘	De Placido S Scambia G Di V G	2004	J Clin Oncol2004，22，13：	1
20	Residual neuro-toxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel : the MulticenterItalian Trial in Ovarian cancer( MITO-4) retrospective study 显示文摘	Pignata S De Placido S Biamonte R	2006	BMC Cancer2006，6，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示